SCHEMBL16932353

SCHEMBL16932353

[c]1ccccc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 15/20 0.67
▸ PRKCA P17252 10/20 0.67
▸ PRKCD Q05655 7/20 0.67
▸ EGFR P00533 3/20 0.67
▸ BCR P11274 14/20 0.55
▸ SRC P12931 9/20 0.55
▸ PRKACA P17612 1/20 0.55
▸ PRKACG P22612 1/20 0.55
▸ PRKACB P22694 1/20 0.55
▸ PRKD3 O94806 2/20 0.52
▸ PRKCG P05129 2/20 0.52
▸ PRKCB P05771 2/20 0.52
▸ PRKCH P24723 2/20 0.52
▸ PRKCI P41743 2/20 0.52
▸ PRKCE Q02156 2/20 0.52
▸ PRKCQ Q04759 2/20 0.52
▸ PRKCZ Q05513 2/20 0.52
▸ PRKD1 Q15139 2/20 0.52
▸ LCK P06239 1/20 0.52
▸ ZAP70 P43403 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16932355 0.82 ABL1 (0.76) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL6262145 0.80 ABL1 (1.00) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL29618427 0.79 ABL1 (0.85) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL29557417 0.77 ABL1 (0.72) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL6859862 0.76 ABL1 (0.71) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL3085556 0.76 ABL1 (0.66) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL4373707 0.75 ABL1 (0.72) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL7462310 0.75 ABL1 (0.68) ABL1PRKCAPRKCDEGFRBCR
Phosphoric Acid SCHEMBL7471510 0.75 ABL1 (0.86) ABL1PRKCAPRKCDEGFRBCR
SCHEMBL22068195 0.74 ABL1 (0.68) ABL1PRKCAPRKCDEGFRBCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9579365-B2 Therapeutic ribonucleases QUINTESSENCE BIOSCIENCES, INC. (US) 2017-02-28 — — US disclosed
US-20150209415-A1 THERAPEUTIC RIBONUCLEASES QUINTESSENCE BIOSCIENCES, INC. 2015-07-30 — — US disclosed
Send feedback